BRIEF-U.S. FDA expands approved use of Stivarga to treat liver cancer
* The FDA granted the approval of Stivarga to Bayer Healthcare Pharmaceuticals Inc Source text (http://bit.ly/2pDo2pY) Further company coverage:
April 4 U.S. stocks opened slightly lower on Tuesday as investors fretted over the ability of President Donald Trump to deliver on his policy plans, and the outcome of his potentially tense meeting with Chinese President Xi Jinping later this week.
The Dow Jones Industrial Average was off 16.38 points, or 0.08 percent, at 20,633.83, the S&P 500 was down 4.32 points, or 0.18 percent, at 2,354.52 and the Nasdaq Composite was lower by 14.30 points, or 0.24 percent, at 5,880.38. (Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Savio D'Souza)
TORONTO, April 27 Exiger, a firm that helps businesses monitor compliances such as money laundering regulations, has agreed to buy OutsideIQ, a Canadian startup that specializes in technology that helps businesses assess and manage risk.
SAO PAULO/RIO DE JANEIRO, April 27 Shares in Vale SA slumped the most in two weeks on Thursday, as executives signaled lackluster trends for iron ore prices this year and investors reacted to a first-quarter profit miss with disappointment.